{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:28:27Z","timestamp":1787682507090,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40644-016-0096-y","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T06:39:39Z","timestamp":1478155179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of combined FDG-PET\/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-5136","authenticated-orcid":false,"given":"Johann-Martin","family":"Hempel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kloeckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Krick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pinto dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Schadmand-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Boe\u00dfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Bisdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fottner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Musholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schreckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Miederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"96_CR1","unstructured":"National Cancer Institute (U.S.). SEER Incidence Statistics - SEER Cancer Query Systems. 16.07.2015. http:\/\/seer.cancer.gov\/canques\/incidence.html . Accessed 27 Oct 2016."},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM, et al. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Res. 2014;74:2913\u201321. doi: 10.1158\/0008-5472.CAN-14-0155 .","journal-title":"Cancer Res"},{"key":"96_CR3","volume-title":"Beitr\u00e4ge zur Gesundheitsberichterstattung des Bundes - Krebs in Deutschland 2009\/2010","author":"Robert Koch Institut","year":"2013","unstructured":"Robert Koch Institut. Beitr\u00e4ge zur Gesundheitsberichterstattung des Bundes - Krebs in Deutschland 2009\/2010. 9th ed. Berlin: Robert Koch-Institut; 2013.","edition":"9"},{"key":"96_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2214\/AJR.09.4172","volume":"195","author":"J Mihailovic","year":"2010","unstructured":"Mihailovic J, Prvulovic M, Ivkovic M, Markoski B, Martinov D. MRI versus 131I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma. AJR Am J Roentgenol. 2010;195:1197\u2013203. doi: 10.2214\/AJR.09.4172 .","journal-title":"AJR Am J Roentgenol"},{"key":"96_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1055\/s-0032-1316351","volume":"44","author":"T Weber","year":"2012","unstructured":"Weber T, Ohlhauser D, Hillenbrand A, Henne-Bruns D, Reske SN, Luster M, Reske S. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma. Horm Metab Res. 2012;44:904\u20138. doi: 10.1055\/s-0032-1316351 .","journal-title":"Horm Metab Res"},{"key":"96_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1530\/ERC-11-0068","volume":"18","author":"H-J Song","year":"2011","unstructured":"Song H-J, Xue Y-L, Xu Y-H, Qiu Z-L, Luo Q-Y. Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr Relat Cancer. 2011;18:74. doi: 10.1530\/ERC-11-0068 .","journal-title":"Endocr Relat Cancer"},{"key":"96_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1\u2013133. doi: 10.1089\/thy.2015.0020 .","journal-title":"Thyroid"},{"key":"96_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.semnuclmed.2006.03.002","volume":"36","author":"P Lind","year":"2006","unstructured":"Lind P, Kohlfurst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36:194\u2013205. doi: 10.1053\/j.semnuclmed.2006.03.002 .","journal-title":"Semin Nucl Med"},{"key":"96_CR9","first-page":"vii110","volume":"23","author":"F Pacini","year":"2012","unstructured":"Pacini F, Castagna MG, Brilli L, Pentheroudakis G, Group, on behalf of the ESMO Guidelines Working. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vii110\u20139. doi: 10.1093\/annonc\/mds230 .","journal-title":"Ann Oncol"},{"key":"96_CR10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00259-007-0634-8","volume":"35","author":"LS Freudenberg","year":"2008","unstructured":"Freudenberg LS, Antoch G, Frilling A, Jentzen W, Rosenbaum SJ, K\u00fchl H, et al. Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET\/CT and FDG-PET. Eur J Nucl Med Mol Imaging. 2008;35:950\u20137. doi: 10.1007\/s00259-007-0634-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00259-006-0276-2","volume":"34","author":"M Zoller","year":"2007","unstructured":"Zoller M, Kohlfuerst S, Igerc I, Kresnik E, Gallowitsch H-J, Gomez I, Lind P. Combined PET\/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? Eur J Nucl Med Mol Imaging. 2007;34:487\u201395. doi: 10.1007\/s00259-006-0276-2 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/01.mlg.0000154725.00787.00","volume":"115","author":"Z Nahas","year":"2005","unstructured":"Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, et al. The role of positron emission tomography\/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope. 2005;115:237\u201343. doi: 10.1097\/01.mlg.0000154725.00787.00 .","journal-title":"Laryngoscope"},{"key":"96_CR13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s002590050493","volume":"26","author":"F Gr\u00fcnwald","year":"1999","unstructured":"Gr\u00fcnwald F, K\u00e4licke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med. 1999;26:1547\u201352.","journal-title":"Eur J Nucl Med"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s002590050158","volume":"24","author":"M Dietlein","year":"1997","unstructured":"Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med. 1997;24:1342\u20138.","journal-title":"Eur J Nucl Med"},{"key":"96_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11604-011-0572-z","volume":"29","author":"S Nagamachi","year":"2011","unstructured":"Nagamachi S, Wakamatsu H, Kiyohara S, Nishii R, Mizutani Y, Fujita S, et al. Comparison of diagnostic and prognostic capabilities of (1)(8)F-FDG-PET\/CT, (1)(3)(1)I-scintigraphy, and diffusion-weighted magnetic resonance imaging for postoperative thyroid cancer. Jpn J Radiol. 2011;29:413\u201322. doi: 10.1007\/s11604-011-0572-z .","journal-title":"Jpn J Radiol"},{"key":"96_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejrad.2007.12.004","volume":"70","author":"S-J Kim","year":"2009","unstructured":"Kim S-J, Lee TH, Kim I-J, Kim Y-K. Clinical implication of F-18 FDG PET\/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin. Eur J Radiol. 2009;70:17\u201324. doi: 10.1016\/j.ejrad.2007.12.004 .","journal-title":"Eur J Radiol"},{"key":"96_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/hed.23881","volume":"38","author":"R Caetano","year":"2016","unstructured":"Caetano R, Bastos CR, de Oliveira IA, da Silva RM, Fortes C, Pepe VL, et al. Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis. Head Neck. 2016;38:316\u201327. doi: 10.1002\/hed.23881 .","journal-title":"Head Neck"},{"key":"96_CR18","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00405-012-2205-2","volume":"270","author":"G Treglia","year":"2013","unstructured":"Treglia G, Muoio B, Giovanella L, Salvatori M. The role of positron emission tomography and positron emission tomography\/computed tomography in thyroid tumours: an overview. Eur Arch Otorhinolaryngol. 2013;270:1783\u20137. doi: 10.1007\/s00405-012-2205-2 .","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"96_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.biopha.2006.07.008","volume":"60","author":"C Nanni","year":"2006","unstructured":"Nanni C, Rubello D, Fanti S, Farsad M, Ambrosini V, Rampin L, et al. Role of 18F-FDG-PET and PET\/CT imaging in thyroid cancer. Biomed Pharmacother. 2006;60:409\u201313. doi: 10.1016\/j.biopha.2006.07.008 .","journal-title":"Biomed Pharmacother"},{"key":"96_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00259-012-2248-z","volume":"40","author":"I Platzek","year":"2013","unstructured":"Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Langner J, Schramm G, et al. PET\/MRI in head and neck cancer: initial experience. Eur J Nucl Med Mol Imaging. 2013;40:6\u201311. doi: 10.1007\/s00259-012-2248-z .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR21","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/RLU.0b013e318212c872","volume":"36","author":"P Bhargava","year":"2011","unstructured":"Bhargava P, Rahman S, Wendt J. Atlas of Confounding Factors in Head and Neck PET\/CT Imaging. Clin Nucl Med. 2011;36:e20\u20139. doi: 10.1097\/RLU.0b013e318212c872 .","journal-title":"Clin Nucl Med"},{"key":"96_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1097\/00005537-200111000-00006","volume":"111","author":"ND Gross","year":"2001","unstructured":"Gross ND, Weissman JL, Talbot JM, Andersen PE, Wax MK, Cohen JI, et al. MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope. 2001;111:1905\u20139. doi: 10.1097\/00005537-200111000-00006 .","journal-title":"Laryngoscope"},{"key":"96_CR23","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00259-011-1866-1","volume":"38","author":"J Nagarajah","year":"2011","unstructured":"Nagarajah J, Jentzen W, Hartung V, Rosenbaum-Krumme S, Mikat C, Heusner TA, et al. Diagnosis and dosimetry in differentiated thyroid carcinoma using 124I PET: comparison of PET\/MRI vs PET\/CT of the neck. Eur J Nucl Med Mol Imaging. 2011;38:1862\u20138. doi: 10.1007\/s00259-011-1866-1 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3238\/arztebl.2014.0417","volume":"111","author":"F Dammann","year":"2014","unstructured":"Dammann F, Bootz F, Cohnen M, Hassfeld S, Tatagiba M, K\u00f6sling S. Diagnostic imaging modalities in head and neck disease. Dtsch Arztebl Int. 2014;111:417\u201323. doi: 10.3238\/arztebl.2014.0417 .","journal-title":"Dtsch Arztebl Int"},{"key":"96_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/RMR.0b013e318572b76","volume":"18","author":"A Miyakoshi","year":"2007","unstructured":"Miyakoshi A, Dalley RW, Anzai Y. Magnetic resonance imaging of thyroid cancer. Top Magn Reson Imaging. 2007;18:293\u2013302. doi: 10.1097\/RMR.0b013e318572b76 .","journal-title":"Top Magn Reson Imaging"},{"key":"96_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s00259-014-2707-9","volume":"41","author":"MA Queiroz","year":"2014","unstructured":"Queiroz MA, H\u00fcllner M, Kuhn F, Huber G, Meerwein C, Kollias S, et al. PET\/MRI and PET\/CT in follow-up of head and neck cancer patients. Eur J Nucl Med Mol Imaging. 2014;41:1066\u201375. doi: 10.1007\/s00259-014-2707-9 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0972-3919.63590","volume":"25","author":"A Daftary","year":"2010","unstructured":"Daftary A. PET-MRI: Challenges and new directions. Indian J Nucl Med. 2010;25:3\u20135. doi: 10.4103\/0972-3919.63590 .","journal-title":"Indian J Nucl Med"},{"key":"96_CR28","doi-asserted-by":"publisher","unstructured":"Binse I, Poeppel TD, Ruhlmann M, Gomez B, Umutlu L, Bockisch A, Rosenbaum-Krumme SJ. Imaging with I in differentiated thyroid carcinoma: is PET\/MRI superior to PET\/CT? Eur J Nucl Med Mol Imaging. 2015. doi: 10.1007\/s00259-015-3288-y","DOI":"10.1007\/s00259-015-3288-y"},{"key":"96_CR29","doi-asserted-by":"publisher","unstructured":"Dercle L, Deandreis D, Terroir M, Leboulleux S, Lumbroso J, Schlumberger M, et al. Evaluation of I PET\/CT and I PET\/MRI in the management of patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016. doi: 10.1007\/s00259-016-3334-4","DOI":"10.1007\/s00259-016-3334-4"},{"key":"96_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00259-015-3195-2","volume":"43","author":"A Vrachimis","year":"2016","unstructured":"Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schafers M, Stegger L. (18)FFDG PET\/CT outperforms (18)FFDG PET\/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016;43:212\u201320. doi: 10.1007\/s00259-015-3195-2 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"96_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1089\/thy.2015.0062","volume":"25","author":"JL Wiebel","year":"2015","unstructured":"Wiebel JL, Esfandiari NH, Papaleontiou M, Worden FP, Haymart MR, Wiebel JL, Worden FP. Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer. Thyroid. 2015;25:1026\u201332. doi: 10.1089\/thy.2015.0062 .","journal-title":"Thyroid"},{"key":"96_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/MLR.0b013e3182928fd5","volume":"51","author":"RW Gimbel","year":"2013","unstructured":"Gimbel RW, Fontelo P, Stephens MB, Olsen CH, Bunt C, Ledford CJW, et al. Radiation exposure and cost influence physician medical image decision making: a randomized controlled trial. Med Care. 2013;51:628\u201332. doi: 10.1097\/MLR.0b013e3182928fd5 .","journal-title":"Med Care"},{"key":"96_CR34","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/cncr.29210","volume":"121","author":"JL Wiebel","year":"2015","unstructured":"Wiebel JL, Banerjee M, Muenz DG, Worden FP, Haymart MR. Trends in imaging after diagnosis of thyroid cancer. Cancer. 2015;121:1387\u201394. doi: 10.1002\/cncr.29210 .","journal-title":"Cancer"},{"key":"96_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s11547-014-0474-0","volume":"120","author":"Q Chen","year":"2015","unstructured":"Chen Q, Raghavan P, Mukherjee S, Jameson MJ, Patrie J, Xin W, et al. Accuracy of MRI for the diagnosis of metastatic cervical lymphadenopathy in patients with thyroid cancer. Radiol Med. 2015;120:959\u201366. doi: 10.1007\/s11547-014-0474-0 .","journal-title":"Radiol Med"},{"key":"96_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiology.191.1.8134580","volume":"191","author":"EL Thurfjell","year":"1994","unstructured":"Thurfjell EL, Lernevall KA, Taube AA. Benefit of independent double reading in a population-based mammography screening program. Radiology. 1994;191:241\u20134. doi: 10.1148\/radiology.191.1.8134580 .","journal-title":"Radiology"},{"key":"96_CR37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0009-9260(05)81111-0","volume":"48","author":"I Anttinen","year":"1993","unstructured":"Anttinen I, Pamilo M, Soiva M, Roiha M. Double reading of mammography screening films\u2014one radiologist or two? Clin Radiol. 1993;48:414\u201321.","journal-title":"Clin Radiol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-016-0096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:42:29Z","timestamp":1498344149000},"score":1,"resource":{"primary":{"URL":"http:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-016-0096-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1186\/s40644-016-0096-y","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]},"article-number":"37"}}